Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
about
Fructosamine 3-kinase-related protein and deglycation in human erythrocytesFructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytesPrevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complicationSite-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetesMagnesium-dependent phosphatase-1 is a protein-fructosamine-6-phosphatase potentially involved in glycation repairPossible role of fructosamine 3-kinase genotyping for the management of diabetic patients.The sour side of neurodegenerative disorders: the effects of protein glycation.Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coli.Reduced fructosamine-3-kinase activity and its mRNA in human distal colorectal carcinomaFructoselysine 3-epimerase, an enzyme involved in the metabolism of the unusual Amadori compound psicoselysine in Escherichia coliIdentification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein.Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme.Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells.Purification and identification of activating enzymes of CS-0777, a selective sphingosine 1-phosphate receptor 1 modulator, in erythrocytesTissue-specific variation in glycation of proteins in diabetes: evidence for a functional role of amadoriase enzymes.Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycationThe pathogenic role of Maillard reaction in the aging eye.Enzymatic repair of Amadori products.Enzymatic deglycation of Amadori products in bacteria: mechanisms, occurrence and physiological functions.Advanced glycation end products: role in pathology of diabetic cardiomyopathy.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Baking, ageing, diabetes: a short history of the Maillard reaction.The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.Advancing the development of glycated protein biosensing technology: next-generation sensing molecules.Increased protein glycation in fructosamine 3-kinase-deficient mice.Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.Genetic variability of the fructosamine 3-kinase gene in diabetic patients.Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress.Functional analysis of fructosyl-amino acid oxidases of Aspergillus oryzae.Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1).Specific tandem mass spectrometric detection of AGE-modified arginine residues in peptides.Identification of protein-ribulosamine-5-phosphatase as human low-molecular-mass protein tyrosine phosphatase-A.Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry.14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.Substrate specificity engineering of Escherichia coli derived fructosamine 6-kinase.
P2860
Q24528116-E2DF5FC4-9E82-4A54-BAE9-089ADC279DCBQ24534263-F292932C-9646-45E5-BBE3-871C361C3A47Q26751110-D3041303-8930-4F23-BE07-F6D7F5BE1A31Q26865565-E0337A17-AD93-4678-AD8E-C16BA8ABA00EQ28569023-69202F48-7E38-49CD-AB06-084A89CD0E23Q30378957-5F7E399A-BDD8-4F5F-A0F7-84F61F6DEE7AQ30386079-06E9656F-F909-48F6-8E6A-353391A112A5Q30708333-2CF55053-D96D-49E3-984F-87903114A306Q34110891-AD90DF32-B39F-40BD-8EB8-5026013288A9Q34279306-C3DDABBD-E69B-4AE3-BFEA-E7CF0C61A8F2Q34315577-25A43AC0-4878-4846-9FA7-F5E5A70847EAQ34343609-64732103-3FF5-48C7-84A2-EEE60886AF5EQ34393053-7D23C676-8B72-4FCA-B62A-51F5A392B48AQ34436032-B16C7041-899A-49E4-B01C-F781AA448ADDQ34490546-0C9F05CA-DFC9-45E3-A617-60DE73809CA9Q35107430-925FF947-E818-477E-81C6-6639BC170029Q36204041-C8787B25-8047-4423-911F-0408A07386B9Q36969806-3D0FE89E-2D81-4975-AB91-0E5129D3345AQ37072018-E635D609-759C-48CF-AC5C-F7323F3B3CEFQ37112969-6D48DF65-5335-4191-A098-29E1DBBDEEE9Q37230025-F6ADE0AE-784B-4724-9194-DC1B6CCB193BQ37801857-76A27AC6-9C6C-43D5-BCDF-734F76987B8BQ37802272-1766C99C-ACBA-4B29-A5FC-7DA359BA6CFDQ37846575-2D3A0A6A-B3F4-4676-AD12-FC43D5DFA917Q38081119-FE73F1D6-B9C3-4CC1-B374-D66A16D300B6Q38096444-CFF48B05-5787-4DFA-9718-71251D39A2B4Q38232036-BB1B2B13-C61C-46DA-A30F-0A987D3896C5Q38241689-9C240609-66D7-40FE-96DA-EE45ECD3A880Q38334761-B3815BE1-1F10-4A2A-B43C-F2CD99C39980Q38663198-7FDC148C-AF63-4FD8-9689-2778B44E86F4Q39285661-9DB96730-86FE-4F96-82BE-A0A06818C99FQ39787188-36DB343E-7143-4888-A034-A0BA7CCFBC20Q40047034-E9904FE3-68D9-444E-BB64-6554B029C454Q40172628-FDE97D67-80E3-40B4-8B39-845240E6D50CQ40194230-4E49A6E3-DB9B-4BDA-A054-09CADDB1345BQ41176710-66CE8F98-3F1E-4B24-AA5E-0C66C6D66D83Q41807890-580B0073-C262-4282-8043-7B422B364F00Q42048767-8880D092-9346-4807-96E5-605100702586Q42125847-71C7EB14-AF31-4538-9525-304EF0B9E437Q44994541-09E9D0BB-BDA9-423A-B6CF-948416B70E27
P2860
Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@ast
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@en
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@nl
type
label
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@ast
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@en
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@nl
prefLabel
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@ast
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@en
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@nl
P2093
P1433
P1476
Human fructosamine-3-kinase: p ...... evidence of activity in vivo.
@en
P2093
Beisswenger PJ
Szwergold BS
P304
P356
10.2337/DIABETES.50.9.2139
P407
P577
2001-09-01T00:00:00Z